News Home

Should Medical Devices Stock Boston Scientific Corporation (BSX) Be in Your Portfolio Tuesday?

Tuesday, December 05, 2023 03:43 PM | InvestorsObserver Analysts

Mentioned in this article

Should Medical Devices Stock Boston Scientific Corporation (BSX) Be in Your Portfolio Tuesday?

A rating of 98 puts Boston Scientific Corporation (BSX) near the top of the Medical Devices industry according to InvestorsObserver. Boston Scientific Corporation's score of 98 means it scores higher than 98% of stocks in the industry. Boston Scientific Corporation also received an overall rating of 73, putting it above 73% of all stocks. Medical Devices is ranked 79 out of the 148 industries.

Overall Score - 73
BSX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on BSX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 73 would rank higher than 73 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Boston Scientific Corporation Stock Today?

Boston Scientific Corporation (BSX) stock is higher by 0.31% while the S&P 500 is down -0.06% as of 3:35 PM on Tuesday, Dec 5. BSX has risen $0.17 from the previous closing price of $54.77 on volume of 3,232,766 shares. Over the past year the S&P 500 is up 14.21% while BSX has risen 20.96%. BSX earned $0.82 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 67.23. Click Here to get the full Stock Report for Boston Scientific Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App